SYNEOS HEALTH, INC.

(SYNH)
  Report
Delayed Nasdaq  -  05/16 04:00:00 pm EDT
69.96 USD   -0.21%
05/10Syneos Health Leaders Recognized by HBA
AQ
05/02Syneos Health Names Michelle Keefe as Next Chief Executive Officer
AQ
05/02Syneos Health Reports First Quarter 2022 Results
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Citigroup Downgrades Syneos Health to Neutral From Buy, Adjusts Price Target to $105 From $115

12/15/2021 | 09:20am EDT


ę MT Newswires 2021
All news about SYNEOS HEALTH, INC.
05/10Syneos Health Leaders Recognized by HBA
AQ
05/02Syneos Health Names Michelle Keefe as Next Chief Executive Officer
AQ
05/02Syneos Health Reports First Quarter 2022 Results
AQ
04/29SYNEOS HEALTH, INC. : Change in Directors or Principal Officers, Financial Statements and ..
AQ
04/29SYNEOS HEALTH : Q1 2022 Financial Results Presentation
PU
04/29Syneos Health Promotes Michelle Keefe to CEO, Michael Brooks to COO
MT
04/29Syneos Health's Q1 Adjusted Earnings, Revenue Increase; Boosts FY22 EPS Guidance
MT
04/29Earnings Flash (SYNH) SYNEOS HEALTH Posts Q1 EPS $1.01, vs. Street Est of $0.96
MT
04/29Earnings Flash (SYNH) SYNEOS HEALTH Posts Q1 Revenue $1.34B, vs. Street Est of $1.325B
MT
04/29TRANSCRIPT : Syneos Health, Inc., Q1 2022 Earnings Call, Apr 29, 2022
CI
More news
Analyst Recommendations on SYNEOS HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 5 670 M - -
Net income 2022 296 M - -
Net Debt 2022 2 684 M - -
P/E ratio 2022 24,6x
Yield 2022 -
Capitalization 7 176 M 7 176 M -
EV / Sales 2022 1,74x
EV / Sales 2023 1,54x
Nbr of Employees 26 751
Free-Float 59,7%
Chart SYNEOS HEALTH, INC.
Duration : Period :
Syneos Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYNEOS HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 69,96 $
Average target price 92,60 $
Spread / Average Target 32,4%
EPS Revisions
Managers and Directors
Michelle Keefe Chief Executive Officer & Director
Jason Michael Meggs Chief Financial Officer
John M. Dineen Chairman
Larry A Pickett Chief Information & Digital Officer
Baba Shetty President-Technology & Data Solutions
Sector and Competitors
1st jan.Capi. (M$)
SYNEOS HEALTH, INC.-31.87%7 176
MODERNA, INC.-46.35%54 199
LONZA GROUP AG-28.13%40 453
IQVIA HOLDINGS INC.-26.83%39 077
SEAGEN INC.-7.80%26 238
ICON PUBLIC LIMITED COMPANY-32.02%17 114